The value of 18F-FDG PET/CT in the systemic evaluation of patients with Rosai–Dorfman disease: a retrospective study and literature review

Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exotique Filiales. 1965;58(6):1169–75.

CAS  Google Scholar 

Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87(1):63–70.

CAS  PubMed  Google Scholar 

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81. https://doi.org/10.1182/blood-2016-01-690636.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahzoni P, Zavareh MH, Bagheri M, Hani N, Moqtader B. Intracranial Rosai–Dorfman Disease. J Res Med Sci. 2012;17(3):304–7.

PubMed  PubMed Central  Google Scholar 

Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19–73.

CAS  PubMed  Google Scholar 

Kutlubay Z, Bairamov O, Sevim A, Demirkesen C, Mat MC. Rosai–Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature. Am J Dermatopathol. 2014;36(4):353–7. https://doi.org/10.1097/DAD.0b013e31829e5564.

Article  PubMed  Google Scholar 

Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CD, McKee PH. Cutaneous Rosai–Dorfman disease is a distinct clinical entity. Am J Dermatopathol. 2002;24(5):385–91. https://doi.org/10.1097/00000372-200210000-00001.

Article  PubMed  Google Scholar 

Sodhi KS, Suri S, Nijhawan R, Kang M, Gautam V. Rosai–Dorfman disease: unusual cause of diffuse and massive retroperitoneal lymphadenopathy. Br J Radiol. 2005;78(933):845–7. https://doi.org/10.1259/bjr/23127241.

Article  CAS  PubMed  Google Scholar 

Bruce-Brand C, Schneider JW, Schubert P. Rosai–Dorfman disease: an overview. J Clin Pathol. 2020;73(11):697–705. https://doi.org/10.1136/jclinpath-2020-206733.

Article  CAS  PubMed  Google Scholar 

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai–Dorfman-Destombes disease. Blood. 2018;131(26):2877–90. https://doi.org/10.1182/blood-2018-03-839753.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Colby T, Arnaud L, Haroche J. Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease. Blood. 2014;124(4):483–92. https://doi.org/10.1182/blood-2014-03-561381.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pi Ca Rsic J, Jaffe R (2018) Pathology of histiocytic disorders and neoplasms and related disorders

Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes AK, Mujtaba B, Garg N. Disease characteristics, radiologic patterns, comorbid diseases, and ethnic differences in 32 patients with Rosai–Dorfman disease. J Comput Assist Tomogr. 2020;44(3):450–61. https://doi.org/10.1097/rct.0000000000000983.

Article  PubMed  Google Scholar 

Vaidya T, Mahajan A, Rane S. Multimodality imaging manifestations of Rosai–Dorfman disease. Acta Radiol Open. 2020;9(8):2058460120946719. https://doi.org/10.1177/2058460120946719.

Article  PubMed  PubMed Central  Google Scholar 

Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai–Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. Am J Roentgenol. 2011;196(2):W187-193. https://doi.org/10.2214/ajr.10.4778.

Article  Google Scholar 

Mahajan S, Nakajima R, Yabe M, Dogan A, Ulaner GA, Yahalom J, Noy A, Diamond EL, Schöder H. Rosai–Dorfman disease-utility of 18F-FDG PET/CT for initial evaluation and follow-up. Clin Nucl Med. 2020;45(6):e260–6. https://doi.org/10.1097/rlu.0000000000003014.

Article  PubMed  PubMed Central  Google Scholar 

Sathyanarayanan V, Issa A, Pinto R, Fayad LE, Loghavi S, Hagemeister F, Westin JR. Rosai–Dorfman disease: the MD Anderson cancer center experience. Clin Lymphoma Myeloma Leuk. 2019;19(11):709–14. https://doi.org/10.1016/j.clml.2019.06.013.

Article  PubMed  Google Scholar 

Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS. Clinicopathological features, treatment approaches, and outcomes in Rosai–Dorfman disease. Haematologica. 2020;105(2):348–57. https://doi.org/10.3324/haematol.2019.219626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu Y, Li Y, Wang J, Jin X, Yang D, Huo H, Li W. Laryngeal Rosai–Dorfman disease (sinus histiocytosis with massive lymphadenopathy): a retrospective study of 5 cases. Biomed Res Int. 2017;2017:8521818. https://doi.org/10.1155/2017/8521818.

Article  PubMed  PubMed Central  Google Scholar 

Maeda Y, Ichimura K. Rosai–Dorfman disease revealed in the upper airway: a case report and review of the literature. Auris Nasus Larynx. 2004;31(3):279–82. https://doi.org/10.1016/j.anl.2004.03.015.

Article  PubMed  Google Scholar 

Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, Villivà N, Mandelli F. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69(1):67–71. https://doi.org/10.1002/ajh.10008.

Article  PubMed  Google Scholar 

Lee M, Ryu KH, Baek HJ, Moon JI, Yoon S, An HJ, Nam IC. Rosai–Dorfman disease with infiltration of IgG4-bearing plasma cells presenting as laryngeal-nasal masses and cervical lymphadenopathy: a case report. Medicine. 2021;100(12):e25165. https://doi.org/10.1097/md.0000000000025165.

Article  PubMed  PubMed Central  Google Scholar 

Tsang JS, Anthony MP, Wong MP, Wong CS. The use of FDG-PET/CT in extranodal Rosai–Dorfman disease of bone. Skeletal Radiol. 2012;41(6):715–7. https://doi.org/10.1007/s00256-012-1382-9.

Article  PubMed  Google Scholar 

Merrell MA, Grenn EE, Orr WS 3rd. Rosai–Dorfman disease of the chest wall following mastectomy for breast cancer. Am Surg. 2022. https://doi.org/10.1177/00031348221091963.

Article  PubMed  Google Scholar 

Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT follow-up of Rosai–Dorfman disease. Clin Nucl Med. 2015;40(8):e420-422. https://doi.org/10.1097/rlu.0000000000000853.

Article  PubMed  Google Scholar 

Xue Q, Miao W. Spontaneous recovery of Rosai–Dorfman disease on FDG PET/CT. Clin Nucl Med. 2017;42(8):608–9. https://doi.org/10.1097/rlu.0000000000001705.

Article  PubMed  Google Scholar 

Zadeh MZ, Wen Z, States LJ, Zhuang H. An isolated osseous Rosai–Dorfman disease shown on FDG PET/CT. Clin Nucl Med. 2019;44(6):485–8. https://doi.org/10.1097/rlu.0000000000002501.

Article  PubMed  Google Scholar 

Pucar D, Laskin WB, Saperstein L. Isolated multinodular soft-tissue Rosai–Dorfman disease on FDG PET/CT. Clin Nucl Med. 2018;43(2):e53–5. https://doi.org/10.1097/rlu.0000000000001921.

Article  PubMed  Google Scholar 

Liu T, Cao X. Successful treatment of multisystemic Rosai–Dorfman disease with lenalidomide and dexamethasone: a case report. Ann Hematol. 2022;101(6):1351–3. https://doi.org/10.1007/s00277-021-04719-1.

Article  PubMed  Google Scholar 

Fathala A, Edathodu J, Bakshi N. FDG PET/CT in the evaluation of a rare case of multisystem involvement in newly diagnosed Rosai–Dorfman-Destombes disease. Saudi J Med Med Sci. 2021;9(2):195–8. https://doi.org/10.4103/sjmms.sjmms_99_20.

Article  PubMed  PubMed Central  Google Scholar 

Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim–Chester disease: imaging findings and potential BRAF mutation biomarker. J Nuclear Med. 2018;59(5):774–9. https://doi.org/10.2967/jnumed.117.200741.

Article  Google Scholar 

Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester disease, Destombes-Rosai–Dorfman disease): from oncogenic mutations to inflammatory disorders. Curr Oncol Rep. 2019;21(7):62. https://doi.org/10.1007/s11912-019-0810-6.

Article  PubMed  Google Scholar 

Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS. The Mayo Clinic Histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim–Chester disease, langerhans cell histiocytosis, and Rosai–Dorfman disease. Mayo Clin Proc. 2019;94(10):2054–71. https://doi.org/10.1016/j.mayocp.2019.02.023.

Article  PubMed  Google Scholar 

Krishnan A, Nassar A, Nieh PT. Rosai–Dorfman disease presenting as extranodal renal mass. Urology. 2005;66(6):1319. https://doi.org/10.1016/j.urology.2005.06.103.

Article  PubMed  Google Scholar 

El Majdoub A, El Houari A, Chbani L, El Fatemi H, Khallouk A, Farih MH. Isolated localization of Rosai Dorfman disease as renal mass: a case report and review of literature. Pan Afr Med J. 2016;24:64. https://doi.org/10.11604/pamj.2016.24.64.6291.

Article  PubMed  PubMed Central  Google Scholar 

Laubham MP, Darki A. Rosai–Dorfman disease and left ventricular noncompaction cardiomyopathy: A heart failure conundrum. J Nuclear Cardiol. 2018;25(6):1971–5. https://doi.org/10.1007/s12350-018-1408-3.

Article  Google Scholar 

O’Gallagher K, Dancy L, Sinha A, Sado D. Rosai–Dorfman disease and the heart. Intractable Rare Diss Res. 2016;5(1):1–5. https://doi.org/10.5582/irdr.2015.01047.

Article  Google Scholar 

留言 (0)

沒有登入
gif